Quintiles, Inc. (QTRN) Named Preferred Provider in Phase I Market Report
8/9/2013 9:39:58 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles is the preferred Phase I service provider and most frequently cited as the leading provider for complex studies, according to 119 pharmaceutical and biotechnology professionals surveyed in Industry Standard Research’s (ISR) 2013 Phase I Study Trends and Market Outlook Report. This announcement comes on the heels of Quintiles’ recognition as the industry leader and highest in service quality in Phase II/III clinical research in a separate ISR report released in May.
Help employers find you! Check out all the jobs and post your resume.
comments powered by